114 related articles for article (PubMed ID: 34044433)
1. Epidemiology and Clinical Characteristics of Emergency Department Patients with COVID-19 in a Rhode Island Healthcare System.
Naganathan S; Paiva M; Soliman L; Amanullah S; Aluisio AR; Genisca AE
R I Med J (2013); 2021 Jun; 104(5):24-29. PubMed ID: 34044433
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 in Pediatric Patients: Observations from the Initial Phase of the Global Pandemic in Rhode Island.
Levin RA; Tsao HS; Amanullah S; Genisca A; Chapman L
R I Med J (2013); 2021 Feb; 104(1):55-60. PubMed ID: 33517602
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB
Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers.
Wang RC; Murphy CE; Kornblith AE; Kurtz T; Kohn MA
Ann Emerg Med; 2021 May; 77(5):556-557. PubMed ID: 33902837
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
[No Abstract] [Full Text] [Related]
8. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 among Internal Medicine Residents at a Major Academic Medicine Residency Program.
Murphy M; Li WS; Gentilesco B; Toma E; Napoleon SC; Roussel B; Maynard MA; Lu S; Chan PA
R I Med J (2013); 2021 Jun; 104(5):20-23. PubMed ID: 34044432
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
12. Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department.
Laeyendecker O; Hsieh YH; Rothman RE; Dashler G; Kickler T; Fernandez RE; Clarke W; Patel EU; Tobian AAR; Kelen GD; Quinn TC;
Am J Emerg Med; 2021 Oct; 48():261-268. PubMed ID: 34015609
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 Antibodies in Rhode Island From a Statewide Random Sample.
Chan PA; King E; Xu Y; Goedel W; Lasher L; Vargas M; Brindamour K; Huard R; Clyne A; McDonald J; Bandy U; Yokum D; Rogers ML; Chambers L; Napoleon SC; Alexander-Scott N; Hogan JW
Am J Public Health; 2021 Apr; 111(4):700-703. PubMed ID: 33600249
[No Abstract] [Full Text] [Related]
14. Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
Uyoga S; Adetifa IMO; Otiende M; Yegon C; Agweyu A; Warimwe GM; Scott JAG
JAMA; 2021 Oct; 326(14):1436-1438. PubMed ID: 34473191
[TBL] [Abstract][Full Text] [Related]
15. Which parameters support disposition decision in suspected COVID-19 cases in the emergency department (ED): a German clinical cohort study.
Möckel M; Stegemann MS; Burst V; Kümpers P; Risse J; Koehler FC; Schunk D; Hitzek J; Dietrich TE; Slagman A
BMJ Open; 2021 Mar; 11(3):e044853. PubMed ID: 33789854
[TBL] [Abstract][Full Text] [Related]
16. Responding to COVID-19 in an Uninsured Hispanic/Latino Community: Testing, Education and Telehealth at a Free Clinic in Providence.
Barry K; McCarthy M; Melikian G; Almeida-Monroe V; Leonard M; De Groot AS
R I Med J (2013); 2020 Nov; 103(9):41-46. PubMed ID: 33126788
[TBL] [Abstract][Full Text] [Related]
17. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
18. Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.
Hobbs CV; Drobeniuc J; Kittle T; Williams J; Byers P; Satheshkumar PS; Inagaki K; Stephenson M; Kim SS; Patel MM; Flannery B;
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):312-315. PubMed ID: 33661862
[No Abstract] [Full Text] [Related]
19. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of COVID-19 Virus Infection in Semnan province.
Jandaghi E; Hemati M; Mohammadlou M; Jandaghi J; Mirmohammadkhani M; Danaei N; Kokhaei P
Iran J Immunol; 2021 Mar; 18(1):74-81. PubMed ID: 33787516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
